NCT01477892

Evaluation of Safety and Efficacy of Remifentanil in Pediatric Population

Evaluation of Safety and Efficacy of Remifentanil in Preterm Infant

• Status: Completed
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 14 (actual)
• Sponsor: Seoul National University Hospital · Academic / Other
• Sex: All
• Age: 12 Weeks
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate safety and efficacy of continuous infusion of remifentanil in preterm infant with mechanical ventilator for control of procedural pain using two different dosage of remifentanil.

Conditions

• Infant, Preterm

Interventions

Type	Name	Description
DRUG	low dose remifentanil	non-inferiority test for low dose remifentanil 0.1mcg/kg/min compared with high dose remifentanil 0.25mcg/kg/min in pain control

Timeline

• Start date: 2011-12-01
• Primary completion: 2012-04-01
• Completion: 2012-04-01
• First posted: 2011-11-23
• Last updated: 2013-09-13
• Results posted: 2013-09-13

Locations

1 site across 1 country: South Korea